SB, W., T, W., M, H., JJ, M., RA, B., E, K., . . . TE, W. (2020). Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press.
Cita Chicago Style (17a ed.)SB, Wigal, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, y Wilens TE. Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press, 2020.
Cita MLA (8a ed.)SB, Wigal, et al. Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press, 2020.
Precaución: Estas citas no son 100% exactas.